The activation of NF-κB impacts on many cellular processes and, in CLL, constitutive activation of the p65 subunit is associated with increased ex vivo survival of CLL cells, shorter lymphocyte doubling times, and reduced patient survival [15,16]. This evidence concerns the gene NFKB1 and B-cell chronic lymphocytic leukemia.